Search results
UFC 304, UFC 305 dates, main events, live streaming: Will there be fight night this weekend? - The...
The Economic Times· 10 hours agoUFC 304 and UFC 305 are set to be the most awaited events after the conclusion UFC 303. UFC Fight...
Kapil Wadhawan moves NCLAT to challenge insolvency proceedings against him - CNBC TV18
CNBC TV18· 3 days agoKapil Wadhawan, erstwhile promoter of Dewan Housing Finance (DHFL), has moved the appellate tribunal...
AMINA Bank enters strategic partnership with Pyth Network
Retail Banker International· 1 day agoAt a time when digital assets are approaching a new level of development, AMINA Bank is leading the...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 1 day agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...
Reliance Industries Invests Rs 4,330 cr in Retail Unit in FY24
The Economic Times· 16 hours agoReliance Industries infused Rs 4,330 crore into its flagship retail company Reliance Retail in the...
India to discuss silver import spike with UAE amid growing concerns
Business Standard India· 6 days agoNew Delhi will soon take up the matter with Abu Dhabi. The rise in silver imports follows the...
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 1 day agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
Asset manager BlackRock to buy UK data firm Preqin for $3.2 bn in cash
Business Standard India· 3 days agoBlackRock has agreed to buy UK data firm Preqin for 2.55 billion pounds ($3.23 billion) in cash in a...
Zepto draws interest for $250 million more following $665 million raise; General Catalyst, Sovereign...
CNBC Awaaz· 2 days agoApart from General Catalyst, Zepto is also learnt to have received interest from private equity as...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 5 hours agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...